GlassScriptPhysician profile
Beryl Brown
NPI 1245279033
$2,522.55
in general payments reported to CMS, 2019-2025
31 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2021: $172 · 2022: $225 · 2023: $1,443 · 2024: $370 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,828 · Travel and Lodging: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,828.09 |
| Travel and Lodging | $190.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molli Surgical (US) INC | $521.33 | 2023 | |
| Leica Microsystems INC. | $380.00 | 2023 | |
| Mentor Worldwide LLC | $186.67 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Merck Sharp & Dohme LLC | $182.07 | 2023-2024 | Keytruda, Gardasil, Gardasil 9 |
| Medtronic, INC. | $172.21 | 2023 | Plasmablade(Tm), Sonicision, Ligasure |
| Myriad Genetic Laboratories, INC. | $156.08 | 2021-2025 | Myrisk |
| Allergan, INC. | $107.40 | 2019 | |
| Tela Bio, INC. | $98.13 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Novo Nordisk INC | $83.36 | 2022-2024 | Rybelsus, Ozempic, Wegovy |
| Exact Sciences Corporation | $79.46 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $78.13 | 2023 | Xarelto |
| Biohaven Pharmaceutical Holding Company LTD. | $41.62 | 2022 | |
| Innovation Technologies INC | $38.02 | 2024 | Irrisept |
| Teleflex LLC | $36.47 | 2021-2023 | Quikclot |
| Abbvie INC. | $33.53 | 2023 | Vraylar |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $30.18 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.95 | 2022-2024 | Xifaxan |
| Mayne Pharma Commercial LLC | $24.08 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $22.86 | 2023 | Opsumit, Uptravi |
| Abbott Laboratories | $21.99 | 2022 | |
| Lifenet Health | $21.98 | 2025 | Theragenesis Wound Matrix |
| Bard Peripheral Vascular, INC. | $21.48 | 2021 | |
| Glaxosmithkline, LLC. | $21.35 | 2024 | Trelegy Ellipta, Arexvy |
| Heron Therapeutics, INC. | $19.66 | 2022 | |
| Sanara Medtech INC. | $19.33 | 2025 | Celleraterx |
| Astrazeneca Pharmaceuticals LP | $18.13 | 2024 | Airsupra |
| Convatec INC. | $17.62 | 2021 | |
| Davol INC. | $16.70 | 2024 | Phasix Mesh |
| Bioventus LLC | $16.55 | 2022 | |
| Boston Scientific Corporation | $15.91 | 2023 | Watchman Flx |
| Kowa Pharmaceuticals America, INC. | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beryl Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.